

PEVIVA's first-in-class CE-certified cell death biomarker assays M65 ELISA® and M30-Apoptosense® ELISA and the just launched novel broad measuring range version M65 EpiDeath ELISA® have been independently validated by pharmaceutical companies and clinical research centres for diagnostic use in oncology and hepatology.
"Development, production, marketing and sales of biomarker assays to be used for pre-clinical and clinical applications within the fields of hepatology, gastroenterology,organ transplantation, sepsis and cancer" from PEVIVA are quality-certified according to ISO 9001:2008 and ISO 13485:2003.
PEVIVA is the original developer and manufacturer of the well-established M30 CytoDEATHTM monoclonal antibody directed against the caspase-cleaved neo-epitope M30 of Keratin-18 (K18Asp396-NE, ccK18, K18F-M30).
Use the PEVIVA M30 CytoDEATHTM monoclonal antibody provided in a convenient, stabilized stock solution with the widest range of conjugates for FACS, IHC and CTC analysis.